{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-201751","form_type":"8-K","ticker":"OLMA","cik":"0001750284","company_name":"Olema Pharmaceuticals, Inc.","filed_at":"2026-05-01T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.849604+00:00","generated_at":"2026-05-15T00:20:41.221580+00:00","sec_items":["1.01","2.03"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Olema enters 7-year lease for ~38K sq ft corporate HQ in San Francisco","bullets":["Lease with KR Oyster Point II, LLC for 38,176 sq ft on 4th and 5th floors.","Base rent for Phase I (25,048 sq ft) is $12,361,188 over initial term.","Base rent for Phase II (13,128 sq ft) is $6,145,463.76 over initial term.","Initial term 7 years; one-time termination option at 60 months with $1,716,240.96 fee.","Cash security deposit of $427,546.80 required; move-in expected by December 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-201751","json":"https://secwatch.observer/filing/0001193125-26-201751.json","markdown":"https://secwatch.observer/filing/0001193125-26-201751.md","text":"https://secwatch.observer/filing/0001193125-26-201751.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1750284/000119312526201751/0001193125-26-201751-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1750284/000119312526201751/olma-20260427.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T00:20:41.221580+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"36fbe3c1f665312c528d75cf96189b92afcda4d0","claim":"Olema Pharmaceuticals, Inc. entered into Lease with KR Oyster Point II, LLC (effective 2026-04-27).","evidence_excerpt":"On April 27, 2026, Olema Pharmaceuticals, Inc. (the “Company”) entered into a lease agreement (the “Lease”) with KR Oyster Point II, LLC, a Delaware limited liability company (the “Landlord”)","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1750284/000119312526201751/0001193125-26-201751-index.htm","confidence":0.9}],"comparable_filings":[{"accession":"0000790816-26-000019","ticker":null,"company_name":"BRANDYWINE OPERATING PARTNERSHIP, L.P.","filed_at":"2026-06-01T20:30:42+00:00","headline":"Brandywine extends revolver maturity to Dec 2026; shareholders OK 5M share increase for LTIP","event_type":"other_material","sec_items":["1.01","2.03","5.02","5.07","9.01"],"materiality_score":0.4,"calibrated_materiality_score":0.4,"match_reasons":["same fact type: material_agreement","same SEC item: 1.01, 2.03","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0000790816-26-000019","json":"https://secwatch.observer/filing/0000790816-26-000019.json","markdown":"https://secwatch.observer/filing/0000790816-26-000019.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1060386/000079081626000019/0000790816-26-000019-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/790816/000079081626000019/bdn-20260528.htm"},"side_by_side_evidence":{"fact_type":"material_agreement","source_excerpt":"On April 27, 2026, Olema Pharmaceuticals, Inc. (the “Company”) entered into a lease agreement (the “Lease”) with KR Oyster Point II, LLC, a Delaware limited liability company (the “Landlord”)","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1750284/000119312526201751/0001193125-26-201751-index.htm","comparable_excerpt":"tnership, L.P., a Delaware limited partnership (the “Operating Partnership” and, together with the Company, the “Borrowers”) extended the maturity date of the Borrowers’ revolving credit facility (the “Revolving Credit Facility”) provided under the Borrowers’ Second Amended and Restated Credit Agreement, dated as of June 30, 2022 (the “Credit Agreement”), by and among the Borrowers, Bank of America, N.A., as administrative agent and lender, and the other agents and lenders party thereto, for a period of six months from June 30, 2026 to December 30, 2026.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1060386/000079081626000019/0000790816-26-000019-index.htm"}},{"accession":"0001539497-26-001624","ticker":null,"company_name":"BMO 2026-5C14 Mortgage Trust","filed_at":"2026-06-01T18:53:15+00:00","headline":"BMO 2026-5C14 transfers Compass Storage Whole Loan servicing to Benchmark 2026-V22","event_type":"other_material","sec_items":["1.01","9.01"],"materiality_score":0.35,"calibrated_materiality_score":0.35,"match_reasons":["same fact type: material_agreement","same SEC item: 1.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001539497-26-001624","json":"https://secwatch.observer/filing/0001539497-26-001624.json","markdown":"https://secwatch.observer/filing/0001539497-26-001624.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2063015/000153949726001624/0001539497-26-001624-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2063015/000153949726001624/n5711_x18-8k.htm"},"side_by_side_evidence":{"fact_type":"material_agreement","source_excerpt":"On April 27, 2026, Olema Pharmaceuticals, Inc. (the “Company”) entered into a lease agreement (the “Lease”) with KR Oyster Point II, LLC, a Delaware limited liability company (the “Landlord”)","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1750284/000119312526201751/0001193125-26-201751-index.htm","comparable_excerpt":"On March 25, 2026 (the “ Closing Date ”), BMO 2026-5C14 Mortgage Trust (the “ Issuing Entity ”) issued the BMO 2026-5C14 Mortgage Trust, Commercial Mortgage Pass-Through Certificates, Series 2026-5C14, pursuant to a Pooling and Servicing Agreement, dated as of March 1, 2026 (the “ Pooling and Servicing Agreement ”), between BMO Commercial Mortgage Securities LLC, as depositor, Midland Loan Services, a Division of PNC Bank, National Association, as master servicer, CWCapital Asset Management LLC, as special servicer, Pentalpha Surveillance LLC, as operating advisor and as asset representations reviewer, and Computershare Trust Company, National Association, as certificate administrator and as trustee.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/2063015/000153949726001624/0001539497-26-001624-index.htm"}},{"accession":"0001213900-26-054186","ticker":"SNYR","company_name":"Synergy CHC Corp.","filed_at":"2026-05-11T23:59:59+00:00","headline":"Synergy CHC enters up to $36M equity purchase agreement with Hudson Global Ventures","event_type":"other_material","sec_items":["1.01","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same fact type: material_agreement","same SEC item: 1.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-054186","json":"https://secwatch.observer/filing/0001213900-26-054186.json","markdown":"https://secwatch.observer/filing/0001213900-26-054186.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1562733/000121390026054186/0001213900-26-054186-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1562733/000121390026054186/ea0289929-8k_synergy.htm"},"side_by_side_evidence":{"fact_type":"material_agreement","source_excerpt":"On April 27, 2026, Olema Pharmaceuticals, Inc. (the “Company”) entered into a lease agreement (the “Lease”) with KR Oyster Point II, LLC, a Delaware limited liability company (the “Landlord”)","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1750284/000119312526201751/0001193125-26-201751-index.htm","comparable_excerpt":"On May 8, 2026, Synergy CHC Corp. (the “Company”) entered into an equity purchase agreement (the “Purchase Agreement”) with Hudson Global Ventures, LLC (the “Investor”), pursuant to which the Company has the right, but not the obligation, to direct the Investor to purchase up to $36,000,000 of the Company’s common stock","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1562733/000121390026054186/0001213900-26-054186-index.htm"}},{"accession":"0001500217-26-000035","ticker":"AAT","company_name":"American Assets Trust, Inc.","filed_at":"2026-05-11T23:59:59+00:00","headline":"AAT board raises Rady Trust ownership cap to 21.9%, lowers general limit to 6.775%","event_type":"other_material","sec_items":["1.01","3.03","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same fact type: material_agreement","same SEC item: 1.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001500217-26-000035","json":"https://secwatch.observer/filing/0001500217-26-000035.json","markdown":"https://secwatch.observer/filing/0001500217-26-000035.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1500217/000150021726000035/0001500217-26-000035-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1500217/000150021726000035/aat-20260511.htm"},"side_by_side_evidence":{"fact_type":"material_agreement","source_excerpt":"On April 27, 2026, Olema Pharmaceuticals, Inc. (the “Company”) entered into a lease agreement (the “Lease”) with KR Oyster Point II, LLC, a Delaware limited liability company (the “Landlord”)","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1750284/000119312526201751/0001193125-26-201751-index.htm","comparable_excerpt":"On May 11, 2026, American Assets Trust, Inc. (the \"Company\") entered into a Voting Support Agreement (the \"Voting Agreement\") with the Ernest Rady Trust U/D/T March 10, 1983 (the \"Rady Trust\"), the Evelyn Shirley Rady Trust U/D/T March 10, 1983, and American Assets, Inc. (collectively, the \"Stockholder\").","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1500217/000150021726000035/0001500217-26-000035-index.htm"}},{"accession":"0001213900-26-053856","ticker":null,"company_name":"21Shares Polkadot ETF","filed_at":"2026-05-08T23:59:59+00:00","headline":"21Shares Polkadot ETF enters Figment staking agreement; 26.5% of rewards to service providers","event_type":"other_material","sec_items":["1.01","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same fact type: material_agreement","same SEC item: 1.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-053856","json":"https://secwatch.observer/filing/0001213900-26-053856.json","markdown":"https://secwatch.observer/filing/0001213900-26-053856.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2054247/000121390026053856/0001213900-26-053856-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2054247/000121390026053856/ea0289774-8k_21shares.htm"},"side_by_side_evidence":{"fact_type":"material_agreement","source_excerpt":"On April 27, 2026, Olema Pharmaceuticals, Inc. (the “Company”) entered into a lease agreement (the “Lease”) with KR Oyster Point II, LLC, a Delaware limited liability company (the “Landlord”)","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1750284/000119312526201751/0001193125-26-201751-index.htm","comparable_excerpt":"On May 4, 2026, 21Shares Polkadot ETF (the “Trust”) entered into a staking services agreement with Figment Inc., an Ontario corporation (“Figment” and such agreement, the “Figment Agreement”),","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/2054247/000121390026053856/0001213900-26-053856-index.htm"}},{"accession":"0000943374-26-000191","ticker":"PBHC","company_name":"Pathfinder Bancorp, Inc.","filed_at":"2026-05-07T23:59:59+00:00","headline":"Pathfinder Bancorp and Castle Creek Amend Registration Rights Agreement, Extending Filing Deadline to May 8, 2027","event_type":"other_material","sec_items":["1.01","9.01"],"materiality_score":0.3,"calibrated_materiality_score":0.3,"match_reasons":["same fact type: material_agreement","same SEC item: 1.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0000943374-26-000191","json":"https://secwatch.observer/filing/0000943374-26-000191.json","markdown":"https://secwatch.observer/filing/0000943374-26-000191.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1609065/000094337426000191/0000943374-26-000191-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1609065/000094337426000191/form8k_050426.htm"},"side_by_side_evidence":{"fact_type":"material_agreement","source_excerpt":"On April 27, 2026, Olema Pharmaceuticals, Inc. (the “Company”) entered into a lease agreement (the “Lease”) with KR Oyster Point II, LLC, a Delaware limited liability company (the “Landlord”)","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1750284/000119312526201751/0001193125-26-201751-index.htm","comparable_excerpt":"On May 4, 2026, the Company and Castle Creek agreed to amend the Registration Rights Agreement to allow the Company to file a resale registration statement by no later than May 8, 2027 to register the resale of the securities.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1609065/000094337426000191/0000943374-26-000191-index.htm"}},{"accession":"0001193125-26-212007","ticker":"ENB","company_name":"ENBRIDGE INC","filed_at":"2026-05-07T23:59:59+00:00","headline":"Enbridge shareholders approve directors, auditor, say-on-pay, and rights plan at AGM","event_type":"other_material","sec_items":["1.01","3.03","5.07","9.01"],"materiality_score":0.4,"calibrated_materiality_score":0.4,"match_reasons":["same fact type: material_agreement","same SEC item: 1.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-212007","json":"https://secwatch.observer/filing/0001193125-26-212007.json","markdown":"https://secwatch.observer/filing/0001193125-26-212007.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/895728/000119312526212007/0001193125-26-212007-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/895728/000119312526212007/enb-20260506.htm"},"side_by_side_evidence":{"fact_type":"material_agreement","source_excerpt":"On April 27, 2026, Olema Pharmaceuticals, Inc. (the “Company”) entered into a lease agreement (the “Lease”) with KR Oyster Point II, LLC, a Delaware limited liability company (the “Landlord”)","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1750284/000119312526201751/0001193125-26-201751-index.htm","comparable_excerpt":"the holders of common shares of Enbridge Inc. (the “Corporation”) voted to amend, reconfirm and approve the Corporation’s shareholder rights plan (the “Rights Plan”) under the terms of an agreement between the Corporation and Computershare Trust Company of Canada (“Computershare”), as rights agent.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/895728/000119312526212007/0001193125-26-212007-index.htm"}},{"accession":"0001437749-26-015613","ticker":"GOVX","company_name":"GeoVax Labs, Inc.","filed_at":"2026-05-07T23:59:59+00:00","headline":"GeoVax raises ~$595k via warrant inducement; issues new warrants for 1M shares at $1.65","event_type":"other_material","sec_items":["1.01","3.02","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same fact type: material_agreement","same SEC item: 1.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-015613","json":"https://secwatch.observer/filing/0001437749-26-015613.json","markdown":"https://secwatch.observer/filing/0001437749-26-015613.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/832489/000143774926015613/0001437749-26-015613-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/832489/000143774926015613/govx20260507_8k.htm"},"side_by_side_evidence":{"fact_type":"material_agreement","source_excerpt":"On April 27, 2026, Olema Pharmaceuticals, Inc. (the “Company”) entered into a lease agreement (the “Lease”) with KR Oyster Point II, LLC, a Delaware limited liability company (the “Landlord”)","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1750284/000119312526201751/0001193125-26-201751-index.htm","comparable_excerpt":"On May 7, 2026, GeoVax Labs Inc. (the “Company”), entered into common stock warrant exercise inducement offer letters (the “Inducement Letters”) with holders (the “Holders”) of existing warrants to purchase shares of the Company’s common stock","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/832489/000143774926015613/0001437749-26-015613-index.htm"}}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}